Literature DB >> 32182051

Changes in Allergenicity of Ovalbumin in Vitro and in Vivo on Conjugation with Quercetin.

Tingting Zhang1, Zongyi Hu1,2, Yongwei Cheng1,3, Haoxie Xu1, Tanja Cirkovic Velickovic4,5, Kan He1, Fan Sun1, Zhendan He1, Zhigang Liu1, Xuli Wu1.   

Abstract

A previous study demonstrated decreased allergenicity in vitro of some food allergens after conjugation with polyphenols. However, little is known about how polyphenol conjugation with food allergens affects in vivo allergenicity. We conjugated a well-known food allergen, ovalbumin (OVA), with quercetin (QUE) to assess the potential allergenicity of OVA in vitro and in vivo in a BALB/c mouse model. QUE could covalently conjugate with OVA and changed the protein structure, which might destroy and/or mask OVA epitopes. Conjugation with QUE decreased IgE binding properties and the release capacity of the conjugated OVA. In vivo, as compared with native protein, conjugation with QUE decreased the levels of IgE, IgG1, IgG, plasma histamine, and mast cell protease-1 (mMCP-1) on the surface of sensitized mast cells, along with decreased FcεRI+ and c-kit+ expression. The levels of Th2-related cytokines (IL-4, IL-5, IL-13) decreased and that of a Th1-related cytokine (IFN-γ) increased slightly, which suggests that conjugation with QUE modulated the imbalance of the Th1/Th2 immune response. Conjugation of OVA with QUE could reduce OVA allergenicity in vitro and in vivo, which could provide information for reducing food allergenicity by conjugation with polyphenols.

Entities:  

Keywords:  OVA; allergenicity; conjugation; mouse model; quercetin

Mesh:

Substances:

Year:  2020        PMID: 32182051     DOI: 10.1021/acs.jafc.0c00461

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  1 in total

1.  Viridicatol Isolated from Deep-Sea Penicillium Griseofulvum Alleviates Anaphylaxis and Repairs the Intestinal Barrier in Mice by Suppressing Mast Cell Activation.

Authors:  Zhendan Shu; Qingmei Liu; Cuiping Xing; Yafen Zhang; Yu Zhou; Jun Zhang; Hong Liu; Minjie Cao; Xianwen Yang; Guangming Liu
Journal:  Mar Drugs       Date:  2020-10-16       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.